Candel Therapeutics, Inc. · NASDAQ:CADL
FMR LLC reported a 9.30% stake in Candel Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 7, 2025
FMR LLC reported a 9.30% stake in Candel Therapeutics, Inc., 3,923,599 shares, as a passive investor on Dec 31, 2024. Filed Feb 7, 2025 (Schedule 13G).
- Stake
- 9.30%
- Shares
- 3,923,599
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| FMR LLC | 9.30% | 3,923,599 |
| Abigail P. Johnson | 9.30% | 3,923,599 |
Source
Related
- Candel Therapeutics, Inc.
- FMR LLC
- Candel Therapeutics, Inc. shareholders
- Schedule 13G/A · FMR LLC · Feb 7, 2025
- Form 4 · Tak Paul Peter · Sep 11, 2026
- Form 4 · Tyagarajan Seshu · Aug 19, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Barone Francesca · Jul 1, 2026
- Form 4 · Tyagarajan Seshu · Jul 1, 2026